372 related articles for article (PubMed ID: 25536866)
1. Benefits of timely basal insulin control in patients with type 2 diabetes.
Lovre D; Fonseca V
J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
[TBL] [Abstract][Full Text] [Related]
2. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
[TBL] [Abstract][Full Text] [Related]
3. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
[TBL] [Abstract][Full Text] [Related]
5. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
6. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
Berard L; Bonnemaire M; Mical M; Edelman S
Diabetes Obes Metab; 2018 Feb; 20(2):301-308. PubMed ID: 28719066
[TBL] [Abstract][Full Text] [Related]
7. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R;
Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312
[No Abstract] [Full Text] [Related]
8. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.
Dungan K; Binkley P; Osei K
J Diabetes Complications; 2016; 30(1):150-4. PubMed ID: 26475503
[TBL] [Abstract][Full Text] [Related]
9. Role of Devices in Insulin Delivery.
Meneghini LF; McNulty JN
Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
[No Abstract] [Full Text] [Related]
10. Combining basal insulin analogs with glucagon-like peptide-1 mimetics.
Perfetti R
Diabetes Technol Ther; 2011 Sep; 13(9):873-81. PubMed ID: 21711120
[TBL] [Abstract][Full Text] [Related]
11. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
Morales J; Assumpcao-Morales M
Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
Charbonnel B; Schweizer A; Dejager S
Hosp Pract (1995); 2013 Apr; 41(2):93-107. PubMed ID: 23680741
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
14. Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.
Schwartz SS; DeFronzo RA; Umpierrez GE
Postgrad Med; 2015 Mar; 127(2):251-7. PubMed ID: 25547241
[TBL] [Abstract][Full Text] [Related]
15. Safe and appropriate use of insulin and other antihyperglycemic agents in hospital.
Cornish W
Can J Diabetes; 2014 Apr; 38(2):94-100. PubMed ID: 24690504
[TBL] [Abstract][Full Text] [Related]
16. Strategies for insulin therapy in type 2 diabetes.
Edelman SV; Morello CM
South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164
[TBL] [Abstract][Full Text] [Related]
17. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
Blonde L; Baker DE; Davis SN; Ratner RE
J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
[TBL] [Abstract][Full Text] [Related]
18. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.
Raslová K; Bogoev M; Raz I; Leth G; Gall MA; Hâncu N
Diabetes Res Clin Pract; 2004 Nov; 66(2):193-201. PubMed ID: 15533587
[TBL] [Abstract][Full Text] [Related]
19. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
20. ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes.
Brink S; Joel D; Laffel L; Lee WW; Olsen B; Phelan H; Hanas R;
Pediatr Diabetes; 2014 Sep; 15 Suppl 20():193-202. PubMed ID: 25182314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
